Bitcoin RSI: History Repeats? 🚨

Lo, the latest momentum study by the crypto analyst Tony Severino has stirred the hearts of market watchers, as he posted on X on December 6, declaring the surprising similarities between the RSI trends and price movements of the 2023-2026 cycle and those of 2012 to 2015. His comparison, a labyrinth of timing, focuses on the moments when a price bottom began to form, the first peak, a subsequent momentum peak, and finally, a Bearish Divergence, which, like a cunning fox, foreshadows deeper corrective phases.

The Dark Tale of 1.2 Million Lost Jobs: Economic Doom Strikes Again

In the quiet, foreboding shadows of Chicago, Challenger, Gray & Christmas-a firm that deals in the sorrow of displaced souls-has issued a grim report, one that seems to have passed by unnoticed by many: nearly 1.2 million Americans have been cast aside in 2025. It’s a figure that strikes fear into the heart of the observer. The last time such widespread bloodletting of jobs occurred outside of the pandemic was during the so-called ‘Great Recession,’ 16 long years ago, when 1.24 million people were tossed aside, their futures discarded like old shoes.

Binance Employee’s Meme Token Scandal: A Tale of Greed 🚀💰

This suspicious timing caught the attention of crypto community members who quickly noticed the connection. The token name appears to reference an earlier December 4 post from the main Binance account during Binance Blockchain Week. The employee had access to Binance’s official social media channels and used this position to promote a token they were connected to, giving it instant credibility and exposure to over 523,000 followers. 🤝💸

UK Watchdog Seeks Crypto Feedback: Is This the Future of Investment?

In a set of consultation papers released on Monday-because, of course, Monday is the best day to introduce new rules-the FCA is politely requesting that crypto companies submit feedback on proposals intended to “expand consumer access to investments” and change the rules regarding “client categorization and conflicts of interest.” You know, the usual bureaucratic mumbo-jumbo.

Foresite’s Cytokinetics Gamble: A Tale of Greed and Trials

Cytokinetics, Incorporated is a biopharma company that treats muscle biology like a dark art. Its pipeline gleams with potential, though one wonders if the FDA will grant its application for aficamten-or simply wave a bureaucratic broom and say, “Not today, dear inventor.” Strategic alliances and a focused R&D approach keep the ship afloat, though the waters are choppy and the horizon is foggy.

The Vanguard S&P 500 ETF: A Broader Embrace Compared to Vanguard’s Mega Cap Growth

MGK, a beacon for those who find solace in the behemoths of technology, offers a focused view of the U.S. market, targeting the very titans of growth-those rare giants who stride the earth as if impervious to the passage of time. VOO, by contrast, casts a far wider net, seeking the entire landscape of the market, embracing both the giants and the unknown, with a steady, almost philosophical view of balance.